ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Pembrolizumab for Bladder Cancer americanpharmaceuticalreview
January 09, 2020The Food and Drug Administration (FDA) approved pembrolizumab (KEYTRUDA, Merck) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk ...
Pharma Sources Insight January 2025
